MDS Shareholders Approve Sale of Analytical Technologies Business | GenomeWeb

NEW YORK (GenomeWeb News) – MDS shareholders have approved the sale of the firm's Analytical Technologies business to Danaher for $650 million in cash.

Shareholders representing more than 99 percent of MDS' common shares voted in favor of the sale at a meeting held Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.